The Ionic Alliance Group “IAG” is leading the international research, development, and manufacturing of IBAL, a new form of biotechnology.
The Ionic Alliance Community exchanges information, ideas, and data about all potential applications for this technology.
IAG will pursue this mission in a manner which reflects like-minded collaboration that enhances IBAL to remain cost-effective and widely available throughout the world.
These are the objectives of our corporate mission:
Advance, promote, and publicize leading IBAL research.
Ensure that IBAL technology will remain cost-effective and widely available throughout the world.
Investigate the molecular mechanisms and primary targets of IBAL, participate in studies to determine both the potential effects and its most efficacious formulations.
Collaborate with other universities, institutions, and research organizations to further IBAL’s capabilities.
Provide a comprehensive resource for governmental, medical, and scientific professionals and organizations.
IBAL is new biotechnology that will change how we treat and prevent disease.
Every day, more and more information becomes available on IBAL’s potential to revolutionize our society in ways never before thought possible.
Sometimes, reaching out and taking someone's hand is the beginning of a journey.
At other times, it is allowing another to take yours.” - Vera Nazarian
